NADAC acquisition cost data for BENAZEPRIL HCL 10 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 43547033610 | $0.0663 | 2022-12-21 | Rx |
| 43547033650 | $0.0663 | 2022-12-21 | Rx |
| 50268011011 | $0.0663 | 2022-12-21 | Rx |
| 50268011015 | $0.0663 | 2022-12-21 | Rx |
| 65162075210 | $0.0663 | 2022-12-21 | Rx |
| 65162075250 | $0.0663 | 2022-12-21 | Rx |
| 65862011601 | $0.0663 | 2022-12-21 | Rx |
| 43547033610 | $0.0663 | 2022-12-21 | Rx |
| 43547033650 | $0.0663 | 2022-12-21 | Rx |
| 50268011011 | $0.0663 | 2022-12-21 | Rx |
Generic: Benazepril HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $29.6M | 2,679,327 | 628,525 | $0.1408 |
| 2020 | $28.0M | 2,574,712 | 601,830 | $0.1335 |
| 2021 | $27.0M | 2,402,345 | 577,790 | $0.1344 |
| 2022 | $28.5M | 2,276,430 | 554,336 | $0.1480 |
| 2023 | $37.0M | 2,210,119 | 540,761 | $0.1963 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.